S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
MarketBeat Week in Review – 4/8 - 4/12
5 Trends You Need to Know This Quarter
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
MarketBeat Week in Review – 4/8 - 4/12
5 Trends You Need to Know This Quarter
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
MarketBeat Week in Review – 4/8 - 4/12
5 Trends You Need to Know This Quarter
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
MarketBeat Week in Review – 4/8 - 4/12
5 Trends You Need to Know This Quarter
Faced with possibly paying for news, Google removes links to California news sites for some users
The US and UK restrict the trade of Russian-origin metals

Navidea Biopharmaceuticals (NAVB) News Today

$0.04
0.00 (0.00%)
(As of 04/12/2024 ET)
SourceHeadline
MarketBeat logoNavidea Biopharmaceuticals (NYSE:NAVB) Coverage Initiated by Analysts at StockNews.com
americanbankingnews.com - April 13 at 2:30 AM
MarketBeat logoNavidea Biopharmaceuticals (NYSE:NAVB) Earns Sell Rating from Analysts at StockNews.com
americanbankingnews.com - April 5 at 2:10 AM
benzinga.com logoNavidea Biopharmaceutical Stock (OTC:NAVB), Short Interest Report
benzinga.com - February 23 at 3:33 PM
benzinga.com logoNavidea Biopharmaceutical Stock (OTC:NAVB) Dividends: History, Yield and Dates
benzinga.com - February 22 at 2:03 PM
benzinga.com logoNavidea Biopharmaceutical Stock (OTC:NAVB) Insider Trades
benzinga.com - February 22 at 8:57 AM
bizjournals.com logoCentral Ohio public company voluntarily deregisters stock
bizjournals.com - January 29 at 10:42 PM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
finance.yahoo.com - January 26 at 7:39 PM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
finance.yahoo.com - January 26 at 7:39 PM
investing.com logoSuzhou Zelgen Biopharmaceuticals Co Ltd (688266)
investing.com - January 11 at 4:12 AM
msn.com logoNavidea settles litigation with Capital Royalty, stock rallies 30%
msn.com - December 1 at 2:59 PM
markets.businessinsider.com logoNavidea Biopharmaceuticals, CRG Settle All Ongoing Litigation
markets.businessinsider.com - December 1 at 9:59 AM
morningstar.com logoNavidea Biopharmaceuticals Inc NAVB
morningstar.com - November 1 at 12:38 AM
investing.com logoNavidea Biopharmaceuticals faces delisting from NYSE American, plans to move to OTC markets
investing.com - October 26 at 3:48 PM
bizjournals.com logoNYSE American halts trading on Navidea stock after delisting recommended
bizjournals.com - October 6 at 12:34 PM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock
finance.yahoo.com - October 5 at 9:54 PM
tmcnet.com logoNYSE American to Suspend Trading in Navidea Biopharmaceuticals, Inc. (NAVB)
tmcnet.com - October 5 at 4:53 PM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel
finance.yahoo.com - August 10 at 9:44 AM
finance.yahoo.com logoNYSE American starts to delist Navidea stock, company to appeal
finance.yahoo.com - August 1 at 3:24 PM
benzinga.com logoWhy Navidea Biopharmaceuticals Shares Are Nosediving
benzinga.com - July 31 at 10:33 AM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Presses Ahead, Embraces Opportunities
finance.yahoo.com - July 31 at 10:32 AM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American Determination
finance.yahoo.com - July 28 at 9:18 PM
businesswire.com logoNYSE American to Commence Delisting Proceedings Against Navidea Biopharmaceuticals, Inc. (NAVB)
businesswire.com - July 28 at 6:29 PM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial Officer
finance.yahoo.com - July 28 at 7:28 AM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps Down
finance.yahoo.com - July 13 at 6:39 PM
bizjournals.com logoDublin biotech proposes reverse stock split, stock-for-debt swap
bizjournals.com - July 6 at 7:43 AM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain Assets
finance.yahoo.com - June 30 at 9:28 AM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Announces Distribution of Series K Preferred Stock to Holders of its Common Stock
finance.yahoo.com - June 16 at 5:37 PM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone Payment
finance.yahoo.com - June 16 at 2:36 PM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - June 7 at 4:22 PM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Receives NYSE American Notice
finance.yahoo.com - June 2 at 8:32 PM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Investors Purchase $1.1 Million in Preferred Shares at Market
finance.yahoo.com - May 22 at 7:09 PM
investing.com logoNavidea Biopharma (NAVB) Earnings Dates & Reports
investing.com - May 15 at 8:43 AM
msn.com logoNavidea promotes Michael Sherman Blue to CMO post
msn.com - May 11 at 9:35 PM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Drives Strategy Forward, Shifts Approach for Communications
finance.yahoo.com - May 8 at 6:02 PM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
finance.yahoo.com - April 27 at 7:35 PM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694
finance.yahoo.com - April 13 at 5:56 PM
businesswire.com logoNavidea Biopharmaceuticals, Inc. Hires G2G Ventures as Executive Consultants; Chief Medical Officer Steps Down
businesswire.com - March 30 at 5:14 PM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. (AMEX:NAVB) Q4 2022 Earnings Call Transcript
finance.yahoo.com - March 24 at 8:35 AM
finance.yahoo.com logoQ4 2022 Navidea Biopharmaceuticals Inc Earnings Call
finance.yahoo.com - March 22 at 8:44 AM
finance.yahoo.com logoNavidea Biopharmaceuticals Reports Fourth Quarter 2022 Financial Results
finance.yahoo.com - March 21 at 5:05 PM
finance.yahoo.com logoNavidea Biopharmaceuticals to Host Fourth Quarter 2022 Earnings Conference Call and Business Update
finance.yahoo.com - March 15 at 10:28 AM
reuters.com logoNAVB.PH - | Stock Price & Latest News | Reuters
reuters.com - January 24 at 9:35 AM
msn.com logoNavidea stock soars ~25% on upcoming US patent linked to cancer drug pipeline
msn.com - January 3 at 10:19 AM
finance.yahoo.com logoNavidea Biopharmaceuticals Announces the Notice of Allowance for U.S. Patent Application for Key Component of the Company’s Cancer Immunotherapy Pipeline
finance.yahoo.com - January 3 at 8:55 AM
finance.yahoo.com logoNavidea Biopharmaceuticals, Inc. (AMEX:NAVB) Q3 2022 Earnings Call Transcript
finance.yahoo.com - December 28 at 12:01 PM
finance.yahoo.com logoNavidea Biopharmaceuticals Files Appeal in CRG Case
finance.yahoo.com - November 30 at 9:54 PM
finance.yahoo.com logoNavidea Biopharmaceuticals Announces 50th Participant Enrolled in the Company’s Phase 3 Trial in Rheumatoid Arthritis
finance.yahoo.com - November 28 at 4:40 PM
seekingalpha.com logoNavidea Biopharmaceuticals, Inc. (NAVB) Q3 2022 Earnings Call Transcript
seekingalpha.com - November 15 at 10:46 PM
finance.yahoo.com logoCORRECTING and REPLACING Navidea Biopharmaceuticals Reports Third Quarter 2022 Financial Results
finance.yahoo.com - November 14 at 7:22 PM
finance.yahoo.com logoNavidea Biopharmaceuticals Reports Third Quarter 2022 Financial Results
finance.yahoo.com - November 14 at 10:20 AM
Get Navidea Biopharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAVB and its competitors with MarketBeat's FREE daily newsletter.

SHOCKING Altcoin Moves… (Ad)

Bitcoin's recent price boom has sent select altcoins into an absolute FRENZY! Which is why we've gathered 27 crypto experts to share their top picks and predictions as we rapidly approach the Bitcoin halving event this month…

Click here to register now

NAVB Media Mentions By Week

NAVB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NAVB
News Sentiment

0.00

0.63

Average
Medical
News Sentiment

NAVB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NAVB Articles
This Week

1

0

NAVB Articles
Average Week

Get Navidea Biopharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAVB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:NAVB) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners